An Overview on Screening Methods for Lysine Specific Demethylase 1 (LSD1) Inhibitors-Reference-Cited by-同舟云学术

An Overview on Screening Methods for Lysine Specific Demethylase 1 (LSD1) Inhibitors

Published:2017-09-11 Issue:23 Volume:24 Page:
ISSN:0929-8673
Container-title:Current Medicinal Chemistry
language:en
Short-container-title:CMC

Author:

Zheng Yi-Chao¹,Chang Jiao¹,Zhang Ting¹,Suo Feng-Zhi¹,Chen Xiao-Bing²,Liu Ying¹,Zhao Bing¹,Yu Bin³,Liu Hong-Min³

Affiliation:

1. Key Laboratory of Advanced Pharmaceutical Technology, Ministry of Education of China; Co-innovation Center of Henan Province for New Drug R & D and Preclinical Safety; Institute of Drug Discovery and Development; School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China

2. Henan Cancer Hospital, Zhengzhou University, Zhengzhou, Henan 450001, China

3. School of Pharmaceutical Sciences, Zhengzhou University, P.O. Box: 450001, Zhengzhou, China

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive comparative study on LSD1 in different cancers and tumor specific LSD1 inhibitors;European Journal of Medicinal Chemistry;2022-10

2. Identification of novel indole derivatives as highly potent and efficacious LSD1 inhibitors;European Journal of Medicinal Chemistry;2022-09

3. Design, synthesis and biological evaluation of 2-aminopyrimidine-based LSD1 inhibitors;Bioorganic Chemistry;2022-04

4. Advances with metal oxide-based nanoparticles as MDR metastatic breast cancer therapeutics and diagnostics;RSC Advances;2022

5. Therapeutic potential of targeting LSD1/ KDM1A in cancers;Pharmacological Research;2022-01